What Elevance Health (ELV) Said on Its Q3 Earnings Call
Elevance Health (NYSE:ELV) raised its 2026 earnings outlook after reporting third-quarter adjusted diluted earnings per share of $6.99, exceeding the company’s expectations as Medicaid, Medicare Advantage and Individual ACA businesses all performed better than anticipated. President and CEO Gail Bo
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo